supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
drug:
Dextromethorphan
supplement:
Glucose
Research Papers that Mention the Interaction
“ Dex decreased basal glucose metabolic clearance to the same extent in LIR and HIR.”
“During OGTT, Dex caused a more prominent increment in glucose in LIR, whereas the increment in insulin was less in LIR (P less than 0.05).”
The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders.“ DEX increased GC postabsorptively (three-fold) P less than 0.005 and during glucose infusion (P less than 0.05) but decreased metabolic clearance and glucose uptake (Rd), which eventually normalized, however.”
“The administration of DEX resulted in significant (P < 0.05) increase in the levels of MDA concentration, TG, TC, LDL, LDH, and glucose but decreased significantly in HDL.”
In vitro antioxidant, antibacterial, and antihyperlipidemic potential of ethanolic Avicennia marina leaves extract supported by metabolic profiling“Reduced cardiac glucose utilization may contribute to the long-term detrimental effects caused by neonatal DEX treatment.”
“The characteristic inhibitory effect of glucose on glucagon secretion was impaired in the islets of the DEX rats, while no direct effects were found on α-cells in islets that were incubated with DEX in vitro.”
“ DEX treatment resulted in increases in the glucose and insulin area under the curve (AUC) during an intraperitoneal glucose tolerance test.”
“ DEX again increased (P < 0.01) glucose , insulin, and leptin concentrations; the delayed elevation in IGF-I concentrations occurred on day 10, 12, and 19, relative to the first day of treatment.”
“ DEX increased (P < 0.001) glucose , insulin, and leptin concentrations and resulted in a delayed increase (P < 0.001) in IGF-I concentrations.”
“ DEX treatment significantly increased endogenous glucose production and decreased whole-body glucose disposal, as well as 2-deoxyglucose (2-DG) uptake by skeletal muscle during euglycemic-hyperinsulinemic clamps.”
“The DEX alone decreased glucose and acetate utilization by bovine and ovine AT during the first 4 d of incubation.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback